Increased expression of antimüllerian hormone and its receptor in endometriosis

Autor: Paola Piomboni, Ana Luiza Lunardi Rocha, Felice Arcuri, Errico Zupi, Patrizia Carrarelli, Giuseppe Belmonte, Mauricio Simões Abrão, Felice Petraglia
Rok vydání: 2014
Předmět:
endometriosis
Adult
Anti-Mullerian Hormone
endocrine system
medicine.medical_specialty
Receptors
Peptide

ENDOMETRIOSE
endocrine system diseases
Endometriosis
Endometrium
Young Adult
Transforming Growth Factor beta
Internal medicine
Receptors
AMH
Humans
Medicine
Prospective Studies
AMHRII
ovarian and deep endometriosis
TGF-β superfamily
Receptor
Prospective cohort study
medicine.diagnostic_test
urogenital system
business.industry
Obstetrics and Gynecology
Transforming growth factor beta superfamily
medicine.disease
female genital diseases and pregnancy complications
medicine.anatomical_structure
Endocrinology
Biomarkers
Female
Receptors
Transforming Growth Factor beta

Gene Expression Regulation
Reproductive Medicine
Hysteroscopy
Peptide
Ovarian Endometriosis
Immunohistochemistry
Settore MED/40 - Ginecologia e Ostetricia
business
hormones
hormone substitutes
and hormone antagonists
Zdroj: Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
ISSN: 0015-0282
Popis: Objective To evaluate antimullerian hormone (AMH) and AMH receptor II (AMHRII) mRNA and protein expression in endometrium and in ovarian or deep lesions of women with endometriosis. Design Prospective study. Setting University hospitals in Italy and Brazil. Patients Patients with endometriosis (n = 55) and healthy women (n = 45). Interventions Specimens of endometrium obtained by hysteroscopy from patients with endometriosis and from healthy control subjects; specimens of ovarian endometriosis (n = 29) or of deep endometriosis (n = 26) were collected by laparoscopy. Serum samples were collected in some endometriotic patients (n = 23) and healthy control subjects (n = 20). Main Outcome Measure(s) AMH and AMHRII mRNA levels were evaluated by quantitative reverse-transcription polymerase chain reaction and protein localization by immunohistochemistry. AMH levels in tissue homogenates and in serum were assessed by ELISA. Result(s) Endometrium from women with endometriosis showed higher AMH and AMHRII mRNA levels than control women, with no significant differences between proliferative and secretory phases. Specimens collected from ovarian or deep endometriosis showed the highest AMH and AMHRII mRNA expression. Immunolocalization study confirmed the high AMH and AMHRII protein expression in endometriotic lesions. No difference of serum AMH levels between the groups was found. Conclusion(s) The increased AMH and AMHRII mRNA and protein expression in endometrium and in endometriotic lesions suggests a possible involvement of AMH in endometriosis.
Databáze: OpenAIRE